The two main causes of implant surgery failure are aseptic loosening and bacterial-induced implant-associated infections. To make bone defect implants effective for a long time, the ideal scaffold should take into account the two functions of osseointegration and anti-infection. Therefore, on the basis of the low-elastic-modulus Ti-10Ta-2Nb-2Zr (TTNZ) alloys developed by the research group in the early stage, this study intends to combine the vancomycin-loaded hydrogel with the 3D-printed through-hole porous titanium alloy scaffold to endow 3D-printed TTNZ scaffolds with antibac-terial properties. The local release rate of vancomycin and the effect of this composite system on osseointegration from the aspects of cell adhesion, cell proliferation, osteogenesis-related gene expression, and the antibacterial properties were investigated by the inhibition zone test and the adhesion/free antibacterial test. The results showed that loading 2.5 wt.% and 5 wt.% vancomycin did not affect the structure of chitosan–hyaluronic acid hydrogel. The properties of the hydrogels were examined by scanning electron microscopy (SEM), Fourier-transform infrared (FT-IR), and vancomycin release experiments in vitro. When combined with porous scaffolds, the drug-loaded hydrogels exhibited slower drug release rates and longer release times. In addition, in vitro studies found that the TTNZ scaffolds loaded with 5 wt.% vancomycin had a certain effect on the expression of osteogenesis-related genes in cells, but the antibacterial effect was the best. The porous scaffolds loaded with 2.5 wt.% vancomycin hydrogel TTNZ scaffolds did not inhibit cell proliferation, adhesion, alkaline phosphatase activity, and osteogenesis-related gene expression, but the antibacterial effect on free bacteria was not as good as that of TTNZ scaffolds loaded with 5 wt.% vancomycin. This study, complementing the advantages of the two and controlling the local release rate of vancomycin, provides a new idea for future 3D printing of titanium alloy stents for anti-infection.
The two major problems of titanium alloy surface of bone/dental implants were the lack of native tissue integration and associated infection. To solve these problems, the development of self-defending implants with intrinsic osteogenic properties has been highlighted, in which titanium alloy surfaces of bone/dental implants are endowed with antibacterial property by silver (Ag) incorporated in biomaterials. In this study, we biofunctionalized the surface of selective laser melting (SLM) manufactured volume-porous Ti-Ta-Nb-Zr scaffolds by using plasma electrolytic oxidation (PEO) as a way to eliminate the peri-operative bacterial load and promote osseointegration. In the experiment, the PEO process operated with three different concentration (1, 1, and 2 g/L) of a AgNO3 solution. As a result, a titanium oxide coating embedded with calcium and phosphorous and Ag was formed by one-step PEO treatment, and a presence of HAp was detected by X-ray diffraction (XRD) and XPS. In addition, Ag ions were found to be released from the scaffolds for at least 28 days, resulting in an effective prevention of bacterial adhesion and a decrease of the number of planktonic bacteria, with no sign of cytotoxicity shown simultaneously. Highly porosity micropores were formed on the surface of scaffolds after oxidation, and the mechanical properties did not show any signs of change. Besides, a strong calcium deposition and osteoconductive effect were found on the surface of PEO-treated Ag scaffolds. To sum up, this study reveals the potential of PEO coatings to biofunctionalize SLM Ti-Ta-Nb-Zr scaffolds with antibacterial agents. The biomaterials developed here, therefore, exploit the biofunctionalized behavior of Ag to offer strong antibacterial behavior and osteogenic promotion without cytotoxicity of Ag against mammalian cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.